Management of CML-blast crisis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of CML-blast crisis

Published:2016-09 Issue:3 Volume:29 Page:295-307
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Hehlmann Rüdiger,Saußele Susanne,Voskanyan Astghik,Silver Richard T.

Funder

Deutsche Krebshilfe

Novartis, Nürnberg, Germany

Kompetenznetz für Akute und Chronische Leukämien

Deutsche José-Carreras Leukämiestiftung

European LeukemiaNet

Roche, Grenzach-Wyhlen

Germany and Essex Pharma, München, Germany

Cancer Research and Treatment Fund, Inc., New York, New York

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference100 articles.

1. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia;Johansson;Acta Haematol,2002

2. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet;Soverini;Blood,2011

3. How I treat CML blast crisis;Hehlmann;Blood,2012

4. Non-random karyotypic evolution in chronic myeloid leukemia;Mitelman;Int J Cancer,1976

5. The karyotype of blastic crisis;Alimena;Cancer Genet Cytogenet,1987

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era – analysis of the European LeukemiaNet Blast Phase Registry;Leukemia;2024-03-28

2. Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era – forgotten but not gone;Leukemia & Lymphoma;2024-02-09

3. Beyond BCR::ABL1—The Role of Genomic Analyses in the Management of CML;Journal of the National Comprehensive Cancer Network;2024-02

4. Prognostic Factors and Clinical Outcomes in Patients with Blast Phase Chronic Myeloid Leukemia;Clinical Laboratory;2024

5. Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia;Acta Haematologica;2023-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3